A systematic review of the genetic mechanisms of dolutegravir resistance

SY Rhee, PM Grant, PL Tzou, G Barrow… - Journal of …, 2019 - academic.oup.com
Background Characterizing the mutations selected by the integrase strand transfer inhibitor
(INSTI) dolutegravir and their effects on susceptibility is essential for identifying viruses less …

HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance

N Mbhele, B Chimukangara, M Gordon - International journal of …, 2021 - Elsevier
Antiretroviral therapy has been imperative in controlling the human immunodeficiency virus
(HIV) epidemic. Most low-and middle-income countries have used nucleoside reverse …

Access to primary healthcare during lockdown measures for COVID-19 in rural South Africa: an interrupted time series analysis

MJ Siedner, JD Kraemer, MJ Meyer, G Harling… - BMJ open, 2020 - bmjopen.bmj.com
Objectives We evaluated whether implementation of lockdown orders in South Africa
affected ambulatory clinic visitation in rural Kwa-Zulu Natal (KZN). Design Observational …

Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study

B Schramm, E Temfack, D Descamps, S Nicholas… - The Lancet …, 2022 - thelancet.com
Background Many countries are now replacing non-nucleoside reverse transcriptase
inhibitor (NNRTI)-based first-line antiretroviral therapy (ART) with a regimen containing …

Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study

J Dorward, Y Sookrajh, T Khubone, J van der Molen… - The Lancet …, 2023 - thelancet.com
Background There are few data assessing the uptake of first-line dolutegravir among men
and women living with HIV in low-income and middle-income countries, and subsequent …

Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries

B Godman, H McCabe, TD Leong… - Expert review of …, 2020 - Taylor & Francis
Introduction There are positive aspects regarding the prescribing of fixed dose combinations
(FDCs) versus prescribing the medicines separately. However, these have to be balanced …

Point-of-care HIV viral load testing: an essential tool for a sustainable global HIV/AIDS response

PK Drain, J Dorward, A Bender, L Lillis… - Clinical microbiology …, 2019 - Am Soc Microbiol
The global public health community has set ambitious treatment targets to end the HIV/AIDS
pandemic. With the notable absence of a cure, the goal of HIV treatment is to achieve …

Advanced HIV: diagnosis, treatment, and prevention

S Prabhu, JI Harwell, N Kumarasamy - The lancet HIV, 2019 - thelancet.com
Substantial progress has been made this century in bringing millions of people living with
HIV into care, but progress for early HIV diagnosis has stalled. Individuals first diagnosed …

Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis

B Chimukangara, RJ Lessells, SY Rhee… - …, 2019 - thelancet.com
Abstract Background South Africa has the largest public antiretroviral therapy (ART)
programme in the world. We assessed temporal trends in pretreatment HIV-1 drug …

Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort

A Mondi, A Cozzi‐Lepri, A Tavelli… - African Journal of …, 2019 - journals.lww.com
Introduction: Concerns about dolutegravir (DTG) tolerability in the real-life setting have
recently arisen. We aimed to estimate the risk of treatment discontinuation and virological …